Key Considerations for Maximizing AAV and LV Production in Transient Transfection Workflows

Key Considerations for Maximizing AAV and LV Production in Transient Transfection Workflows

Transient transfection is a critical component for enabling high titer, large-scale viral vector manufacturing processes. Mirus Bio will present optimization strategies for AAV and LV production in adherent and suspension HEK 293 cells with the TransIT-VirusGEN^® Transfection Reagent. We will also discuss LV and AAV enhancers that further increase functional virus titers and expand manufacturing capabilities for gene and cell therapies.